AI Benchmarks Games, Fake SSDs Plague Gamers, & New Antibiotic Hope Emerges

Here's a news article synthesizing the provided information:

Abxylute Announces GameCube-Inspired Controller for Nintendo Switch 2; AI Benchmarking Expands with New Games; Counterfeit SSDs Surface; Antibiotic Research Advances

Abxylute, a company known for its mobile gamepads, announced a new controller for the upcoming Nintendo Switch 2, drawing inspiration from the classic GameCube controller. The announcement coincided with Google DeepMind's expansion of its "Game Arena" for AI benchmarking and reports of counterfeit Samsung SSDs circulating due to NAND shortages, as well as advancements in antibiotic drug discovery.

Abxylute's new controller, dubbed the N9C, will launch soon on Kickstarter. According to The Verge, the N9C features a design and color scheme reminiscent of the original GameCube controller, appealing to diehard fans of the older console.

In other tech news, Google DeepMind is expanding its "Game Arena" to include more complex scenarios for AI benchmarking. According to a Google DeepMind product manager, Oran Kelly, the platform is being updated with two new games: Werewolf and poker. This expansion aims to benchmark how AI models navigate social dynamics and calculated risk, moving beyond the perfect information environment of games like chess, which was already part of the Game Arena. Live tournaments on Kaggle will showcase the performance of top AI models in these games.

Meanwhile, a NAND shortage has created an environment ripe for counterfeit SSDs. Hacker News reported that a Redditor fell victim to a fake Samsung 990 Pro SSD. The counterfeit drive initially passed basic checks, with Windows detecting the correct product name and 2TB capacity. CrystalDiskInfo, an SSD diagnostic tool, also seemed to confirm the drive's authenticity. However, the drive ultimately performed slower than a USB 2.0 drive, revealing the scam. The report advised caution when purchasing SSDs at unusually low prices during the NAND shortage.

In the realm of medical research, Phys.org reported on the analysis of an "enigmatic enzyme" that could lead to new antibiotic drug discovery. The research, conducted by RIKEN, focuses on understanding the enzyme-driven biosynthesis of antimicrobial medicines to combat antibiotic resistance. The analysis of this unusual enzyme could result in a new generation of antimicrobial medicines to counter antibiotic resistance. The enzyme complex shows nocardicin G positioned next to the 3-ACP group in the enzyme active site.